MCDONALD, Tenn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA, OTC:AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value C103, refractory alloy, and titanium powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, is pleased to announce that it has entered into a five-year exclusive supplier and development agreement with Titomic Limited (ASX:TTT) (“Titomic”) for refractory and titanium alloy spherical powd ...

PresentationSo good morning, and welcome to the Amaero Investor Webinar. I'm Jane Morgan, Investor and Media Relations Manager, and today, I am joined by our Chairman and CEO, Hank Holland. Today's webinar will be a company update followed by a Q&A session.Hank HollandExecutive Chairman & CEO Great. Thank you very much, Jane. Thank you, everyone, for joining. Very pleased to join Investors Day for a brief webinar after we announced yesterday a 5-year exclusive supply agreement with Titomic for spherical ref ...

Summary of Amaero Investor Webinar - September 01, 2025 Company Overview - **Company**: Amaero - **Industry**: Advanced Manufacturing, specifically in metal powders for 3D printing and defense applications Key Points and Arguments Exclusive Supply Agreement - Amaero announced a **five-year exclusive supply agreement** with **Titomic** for spherical refractory and titanium alloy powders, aligning with their strategy in advanced manufacturing [2] - This follows previous agreements with **Admaero Castillon** and **Velo3D**, enhancing Amaero's position in the U.S. defense and aerospace supply chain [2][5] Collaboration with Titomic - The agreement includes a **development collaboration** to produce mission-critical parts requiring spherical powder, which is essential for defense applications [3][4] - Titomic aims to establish a resilient U.S. supply chain for these materials, which is crucial for defense manufacturing [4] Revenue Expectations - For FY2026, the Titomic agreement is expected to contribute **5% to 10%** of Amaero's revenue, with initial shipments of powder planned for the current quarter [8] - The qualification period for the materials will take longer, with collaborative development expected to begin by the end of the calendar year [9] U.S. Manufacturing Strategy - Amaero is focused on reshoring manufacturing capabilities in the U.S., particularly in the defense industrial base, which includes hypersonics and missile defense [11] - The company is investing in additional atomizers to increase production capacity and reduce costs, positioning itself as a low-cost producer in the U.S. market [27][28] Advanced Manufacturing Modalities - Amaero is prioritizing various advanced manufacturing modalities, including additive manufacturing and cold spray, to capture growth opportunities in the defense sector [14][15] Hypersonics Program - The U.S. Department of Defense has greenlit all current hypersonic programs, which is beneficial for Amaero as it increases demand for high-temperature refractory alloys [20][21] Capital Raise and Funding - Amaero is fully funded for a **$72 million Australian CapEx program** and aims to achieve EBITDA positive status by FY2027 [25] - The company has raised **$98.5 million** since May 2022, with a disciplined approach to capital allocation [26] Future Outlook - FY2026 is seen as a transition year for Amaero, with expectations of **$30 to $35 million** in revenue, and plans to announce more commercial contracts [36][37] - The company anticipates having **six to eight long-term agreements** by the end of the fiscal year, providing visibility into FY27 [37] Additional Important Information - Amaero's competitive advantage lies in its advanced manufacturing capabilities, particularly in PM HIP (Pressure Metal Hot Isostatic Pressing), which is crucial for producing high-quality parts for the defense sector [31][33] - The company is engaged with the U.S. Department of Defense for potential grants and has support from congressional members, indicating strong governmental alignment [34][35]